Shopping Cart 0
Cart Subtotal
AED 0

Bausch & Lomb Inc - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 2753

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 5505

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 8258

Details

Summary

Bausch & Lomb Inc (Bausch & Lomb), a subsidiary of Valeant Pharmaceuticals International Inc, is a vision-care company with focus on the protection, enhancement and restoration of eyesight. It offers over-the-counter supplements, eye care products, contact lenses, ophthalmic pharmaceuticals, lens care products, ophthalmic surgical devices and instruments. The company develops, manufactures and markets eye health products for the treatment of a wide range of eye conditions such as glaucoma, conjunctivitis, eye allergies, dry eye and retinal diseases. It has operations across the Americas, Europe, the Middle East, Africa and Asia-Pacific. Bausch & Lomb is headquartered in Bridgewater, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Bausch & Lomb Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Bausch & Lomb Inc Company Overview

Bausch & Lomb Inc Company Snapshot

Bausch & Lomb Inc Pipeline Products and Ongoing Clinical Trials Overview

Bausch & Lomb Inc-Pipeline Analysis Overview

Business Description

Bausch & Lomb Inc-Key Facts

Bausch & Lomb Inc-Major Products and Services

Bausch & Lomb Inc Pipeline Products by Development Stage

Bausch & Lomb Inc Ongoing Clinical Trials by Trial Status

Bausch & Lomb Inc Pipeline Products Overview

Aqualox SiHy Daily Lens

Aqualox SiHy Daily Lens Product Overview

Bausch + Lomb ULTRA Presbyopia Contact Lens

Bausch + Lomb ULTRA Presbyopia Contact Lens Product Overview

BLC-001: SVS

BLC-001: SVS Product Overview

BLC-002: SVS

BLC-002: SVS Product Overview

BLC-003: SVS/MF/fA

BLC-003: SVS/MF/fA Product Overview

BLC-004: Toric

BLC-004: Toric Product Overview

BLC-005: SVS/MF

BLC-005: SVS/MF Product Overview

BLC-006: SVS

BLC-006: SVS Product Overview

BLC-007: MF

BLC-007: MF Product Overview

BLC-008: Astigmatism

BLC-008: Astigmatism Product Overview

BLC-009: Astigmatism

BLC-009: Astigmatism Product Overview

BLS-001: Cataract

BLS-001: Cataract Product Overview

BLS-002: Cataract

BLS-002: Cataract Product Overview

BLS-003: Cataract

BLS-003: Cataract Product Overview

BLS-004: Cataract

BLS-004: Cataract Product Overview

BLS-005: Retina

BLS-005: Retina Product Overview

BLS-006: Cataract

BLS-006: Cataract Product Overview

BLS-007: Cataract

BLS-007: Cataract Product Overview

BLS-008: Cataract

BLS-008: Cataract Product Overview

BLS-009: Retina

BLS-009: Retina Product Overview

BLS-010: Cataract

BLS-010: Cataract Product Overview

BLS-011: Cataract

BLS-011: Cataract Product Overview

BLS-012: Retina

BLS-012: Retina Product Overview

BLS-013: Retina

BLS-013: Retina Product Overview

BLS-014: Refractive

BLS-014: Refractive Product Overview

BLS-015: Cataract

BLS-015: Cataract Product Overview

BLS-016: Cataract

BLS-016: Cataract Product Overview

BLS-018: Retina

BLS-018: Retina Product Overview

BLS-019: Retina

BLS-019: Retina Product Overview

BLS-020: Retina

BLS-020: Retina Product Overview

BLS-021: Retina

BLS-021: Retina Product Overview

BLS-022: Retina

BLS-022: Retina Product Overview

BLS-023: Retina

BLS-023: Retina Product Overview

BLS-024: Retina

BLS-024: Retina Product Overview

BLS-025: Retina

BLS-025: Retina Product Overview

BLS-026: Retina

BLS-026: Retina Product Overview

BLS-027: Retina

BLS-027: Retina Product Overview

BLS-028: Retina

BLS-028: Retina Product Overview

BLS-029: Retina

BLS-029: Retina Product Overview

BLS-030: Retina

BLS-030: Retina Product Overview

BLS-031: Retina

BLS-031: Retina Product Overview

Custom Soft Contact Lens

Custom Soft Contact Lens Product Overview

Customlens

Customlens Product Overview

enVista MX60EF Trifocal IOL

enVista MX60EF Trifocal IOL Product Overview

enVista MX60EF Trifocal IOL Clinical Trial

LAV-001: Aphakia

LAV-001: Aphakia Product Overview

Ophthalmic Viscosurgical Device

Ophthalmic Viscosurgical Device Product Overview

Sarfarazi Elliptical Accommodating IOL

Sarfarazi Elliptical Accommodating IOL Product Overview

TECHNOLAS TENEO 317 Excimer Laser

TECHNOLAS TENEO 317 Excimer Laser Product Overview

TECHNOLAS TENEO 317 Excimer Laser Clinical Trial

Ultra Plus Powers Lens

Ultra Plus Powers Lens Product Overview

XUV-003: Aphakia

XUV-003: Aphakia Product Overview

XUV-004: SVS

XUV-004: SVS Product Overview

XUV-007: MF

XUV-007: MF Product Overview

XUV-009: SVS

XUV-009: SVS Product Overview

XUV-010: Astigmatism

XUV-010: Astigmatism Product Overview

XUV-011: MF

XUV-011: MF Product Overview

XUV-012: SVS

XUV-012: SVS Product Overview

XUV-013: Astigmatism

XUV-013: Astigmatism Product Overview

XUV-014: Presbyopia

XUV-014: Presbyopia Product Overview

XUV-015: MF

XUV-015: MF Product Overview

Bausch & Lomb Inc-Key Competitors

Bausch & Lomb Inc-Key Employees

Bausch & Lomb Inc-Key Employee Biographies

Bausch & Lomb Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Bausch & Lomb Inc, Recent Developments

Apr 29, 2019: Bausch + lomb announces update from antibiotic Antibiotic Resistance Monitoring in Ocular MicRoorganisms (armor) study

Apr 29, 2019: Bausch + lomb invites surgeons to new in-booth experience exchange, events and scientific presentations during the annual meeting of the Annual Meeting of the American Society of Cataract and Refractive Surgery

Apr 29, 2019: Bausch + Lomb announces new scientific analyses featuring surgical and pharmaceutical products will be presented during The Annual Meeting Of The American Society Of Cataract And Refractive Surgery

Apr 26, 2019: Bausch + Lomb presents on Stellaris Elite Vision Enhancement System during The Association For Research In Vision And Ophthalmology Meeting

Apr 22, 2019: Bausch + Lomb reports more than 9.2 million units of contact lens materials diverted from waste stream through ONE by ONE recycling program

Apr 22, 2019: Bausch + Lomb to initiate series of U.S. Clinical trials for Technolas Teneo Excimer Laser

Feb 13, 2019: Bausch + Lomb receives 510(k) clearance for use of the Tangible Hydra-PEG Custom Contact Lens Coating Technology on Several of Its Boston Gas Permeable Lens Materials and Zenlens family of Scleral Lenses

Jan 22, 2019: Bausch + Lomb introduces Zen Multifocal scleral lens for Presbyopia

Dec 05, 2018: Bausch + Lomb receives 510(K) clearance from FDA For Bausch + Lomb Ultra Multifocal for Astigmatism Contact Lenses

Nov 15, 2018: Bausch + Lomb reports more than five million units of contact lens materials recycled by second anniversary of one by one recycling program

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Bausch & Lomb Inc Pipeline Products by Equipment Type

Bausch & Lomb Inc Pipeline Products by Development Stage

Bausch & Lomb Inc Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Bausch & Lomb Inc Pipeline Products and Ongoing Clinical Trials Overview

Bausch & Lomb Inc Pipeline Products by Equipment Type

Bausch & Lomb Inc Pipeline Products by Indication

Bausch & Lomb Inc Ongoing Clinical Trials by Trial Status

Bausch & Lomb Inc, Key Facts

Bausch & Lomb Inc, Major Products and Services

Bausch & Lomb Inc Number of Pipeline Products by Development Stage

Bausch & Lomb Inc Pipeline Products Summary by Development Stage

Bausch & Lomb Inc Ongoing Clinical Trials by Trial Status

Bausch & Lomb Inc Ongoing Clinical Trials Summary

Aqualox SiHy Daily Lens-Product Status

Aqualox SiHy Daily Lens-Product Description

Bausch + Lomb ULTRA Presbyopia Contact Lens-Product Status

Bausch + Lomb ULTRA Presbyopia Contact Lens-Product Description

BLC-001: SVS-Product Status

BLC-001: SVS-Product Description

BLC-002: SVS-Product Status

BLC-002: SVS-Product Description

BLC-003: SVS/MF/fA-Product Status

BLC-003: SVS/MF/fA-Product Description

BLC-004: Toric-Product Status

BLC-004: Toric-Product Description

BLC-005: SVS/MF-Product Status

BLC-005: SVS/MF-Product Description

BLC-006: SVS-Product Status

BLC-006: SVS-Product Description

BLC-007: MF-Product Status

BLC-007: MF-Product Description

BLC-008: Astigmatism-Product Status

BLC-008: Astigmatism-Product Description

BLC-009: Astigmatism-Product Status

BLC-009: Astigmatism-Product Description

BLS-001: Cataract-Product Status

BLS-001: Cataract-Product Description

BLS-002: Cataract-Product Status

BLS-002: Cataract-Product Description

BLS-003: Cataract-Product Status

BLS-003: Cataract-Product Description

BLS-004: Cataract-Product Status

BLS-004: Cataract-Product Description

BLS-005: Retina-Product Status

BLS-005: Retina-Product Description

BLS-006: Cataract-Product Status

BLS-006: Cataract-Product Description

BLS-007: Cataract-Product Status

BLS-007: Cataract-Product Description

BLS-008: Cataract-Product Status

BLS-008: Cataract-Product Description

BLS-009: Retina-Product Status

BLS-009: Retina-Product Description

BLS-010: Cataract-Product Status

BLS-010: Cataract-Product Description

BLS-011: Cataract-Product Status

BLS-011: Cataract-Product Description

BLS-012: Retina-Product Status

BLS-012: Retina-Product Description

BLS-013: Retina-Product Status

BLS-013: Retina-Product Description

BLS-014: Refractive-Product Status

BLS-014: Refractive-Product Description

BLS-015: Cataract-Product Status

BLS-015: Cataract-Product Description

BLS-016: Cataract-Product Status

BLS-016: Cataract-Product Description

BLS-018: Retina-Product Status

BLS-018: Retina-Product Description

BLS-019: Retina-Product Status

BLS-019: Retina-Product Description

BLS-020: Retina-Product Status

BLS-020: Retina-Product Description

BLS-021: Retina-Product Status

BLS-021: Retina-Product Description

BLS-022: Retina-Product Status

BLS-022: Retina-Product Description

BLS-023: Retina-Product Status

BLS-023: Retina-Product Description

BLS-024: Retina-Product Status

BLS-024: Retina-Product Description

BLS-025: Retina-Product Status

BLS-025: Retina-Product Description

BLS-026: Retina-Product Status

BLS-026: Retina-Product Description

BLS-027: Retina-Product Status

BLS-027: Retina-Product Description

BLS-028: Retina-Product Status

BLS-028: Retina-Product Description

BLS-029: Retina-Product Status

BLS-029: Retina-Product Description

BLS-030: Retina-Product Status

BLS-030: Retina-Product Description

BLS-031: Retina-Product Status

BLS-031: Retina-Product Description

Custom Soft Contact Lens-Product Status

Custom Soft Contact Lens-Product Description

Customlens-Product Status

Customlens-Product Description

enVista MX60EF Trifocal IOL-Product Status

enVista MX60EF Trifocal IOL-Product Description

enVista MX60EF Trifocal IOL-A Prospective, Multicenter, Randomized, Active-controlled Clinical Study to Evaluate the Safety and Effectiveness of the enVista One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract Extraction

LAV-001: Aphakia-Product Status

LAV-001: Aphakia-Product Description

Ophthalmic Viscosurgical Device-Product Status

Ophthalmic Viscosurgical Device-Product Description

Sarfarazi Elliptical Accommodating IOL-Product Status

Sarfarazi Elliptical Accommodating IOL-Product Description

TECHNOLAS TENEO 317 Excimer Laser-Product Status

TECHNOLAS TENEO 317 Excimer Laser-Product Description

TECHNOLAS TENEO 317 Excimer Laser-A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser Using LASIK

Ultra Plus Powers Lens-Product Status

Ultra Plus Powers Lens-Product Description

XUV-003: Aphakia-Product Status

XUV-003: Aphakia-Product Description

XUV-004: SVS-Product Status

XUV-004: SVS-Product Description

XUV-007: MF-Product Status

XUV-007: MF-Product Description

XUV-009: SVS-Product Status

XUV-009: SVS-Product Description

XUV-010: Astigmatism-Product Status

XUV-010: Astigmatism-Product Description

XUV-011: MF-Product Status

XUV-011: MF-Product Description

XUV-012: SVS-Product Status

XUV-012: SVS-Product Description

XUV-013: Astigmatism-Product Status

XUV-013: Astigmatism-Product Description

XUV-014: Presbyopia-Product Status

XUV-014: Presbyopia-Product Description

XUV-015: MF-Product Status

XUV-015: MF-Product Description

Bausch & Lomb Inc, Key Employees

Bausch & Lomb Inc, Key Employee Biographies

Bausch & Lomb Inc, Other Locations

Bausch & Lomb Inc, Subsidiaries

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Bausch & Lomb Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Abbott Medical Optics Inc

Carl Zeiss Meditec AG

Essilor International Compagnie Generale d'Optique SA

Johnson & Johnson Vision Care Inc

Harrow Health Inc

CooperVision Inc

Company Profile

Company Profile Title

Summary

Bausch & Lomb Inc (Bausch & Lomb), a subsidiary of Valeant Pharmaceuticals International Inc, is a vision-care company with focus on the protection, enhancement and restoration of eyesight. It offers over-the-counter supplements, eye care products, contact lenses, ophthalmic pharmaceuticals, lens care products, ophthalmic surgical devices and instruments. The company develops, manufactures and markets eye health products for the treatment of a wide range of eye conditions such as glaucoma, conjunctivitis, eye allergies, dry eye and retinal diseases. It has operations across the Americas, Europe, the Middle East, Africa and Asia-Pacific. Bausch & Lomb is headquartered in Bridgewater, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Bausch & Lomb Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Bausch & Lomb Inc Company Overview

Bausch & Lomb Inc Company Snapshot

Bausch & Lomb Inc Pipeline Products and Ongoing Clinical Trials Overview

Bausch & Lomb Inc-Pipeline Analysis Overview

Business Description

Bausch & Lomb Inc-Key Facts

Bausch & Lomb Inc-Major Products and Services

Bausch & Lomb Inc Pipeline Products by Development Stage

Bausch & Lomb Inc Ongoing Clinical Trials by Trial Status

Bausch & Lomb Inc Pipeline Products Overview

Aqualox SiHy Daily Lens

Aqualox SiHy Daily Lens Product Overview

Bausch + Lomb ULTRA Presbyopia Contact Lens

Bausch + Lomb ULTRA Presbyopia Contact Lens Product Overview

BLC-001: SVS

BLC-001: SVS Product Overview

BLC-002: SVS

BLC-002: SVS Product Overview

BLC-003: SVS/MF/fA

BLC-003: SVS/MF/fA Product Overview

BLC-004: Toric

BLC-004: Toric Product Overview

BLC-005: SVS/MF

BLC-005: SVS/MF Product Overview

BLC-006: SVS

BLC-006: SVS Product Overview

BLC-007: MF

BLC-007: MF Product Overview

BLC-008: Astigmatism

BLC-008: Astigmatism Product Overview

BLC-009: Astigmatism

BLC-009: Astigmatism Product Overview

BLS-001: Cataract

BLS-001: Cataract Product Overview

BLS-002: Cataract

BLS-002: Cataract Product Overview

BLS-003: Cataract

BLS-003: Cataract Product Overview

BLS-004: Cataract

BLS-004: Cataract Product Overview

BLS-005: Retina

BLS-005: Retina Product Overview

BLS-006: Cataract

BLS-006: Cataract Product Overview

BLS-007: Cataract

BLS-007: Cataract Product Overview

BLS-008: Cataract

BLS-008: Cataract Product Overview

BLS-009: Retina

BLS-009: Retina Product Overview

BLS-010: Cataract

BLS-010: Cataract Product Overview

BLS-011: Cataract

BLS-011: Cataract Product Overview

BLS-012: Retina

BLS-012: Retina Product Overview

BLS-013: Retina

BLS-013: Retina Product Overview

BLS-014: Refractive

BLS-014: Refractive Product Overview

BLS-015: Cataract

BLS-015: Cataract Product Overview

BLS-016: Cataract

BLS-016: Cataract Product Overview

BLS-018: Retina

BLS-018: Retina Product Overview

BLS-019: Retina

BLS-019: Retina Product Overview

BLS-020: Retina

BLS-020: Retina Product Overview

BLS-021: Retina

BLS-021: Retina Product Overview

BLS-022: Retina

BLS-022: Retina Product Overview

BLS-023: Retina

BLS-023: Retina Product Overview

BLS-024: Retina

BLS-024: Retina Product Overview

BLS-025: Retina

BLS-025: Retina Product Overview

BLS-026: Retina

BLS-026: Retina Product Overview

BLS-027: Retina

BLS-027: Retina Product Overview

BLS-028: Retina

BLS-028: Retina Product Overview

BLS-029: Retina

BLS-029: Retina Product Overview

BLS-030: Retina

BLS-030: Retina Product Overview

BLS-031: Retina

BLS-031: Retina Product Overview

Custom Soft Contact Lens

Custom Soft Contact Lens Product Overview

Customlens

Customlens Product Overview

enVista MX60EF Trifocal IOL

enVista MX60EF Trifocal IOL Product Overview

enVista MX60EF Trifocal IOL Clinical Trial

LAV-001: Aphakia

LAV-001: Aphakia Product Overview

Ophthalmic Viscosurgical Device

Ophthalmic Viscosurgical Device Product Overview

Sarfarazi Elliptical Accommodating IOL

Sarfarazi Elliptical Accommodating IOL Product Overview

TECHNOLAS TENEO 317 Excimer Laser

TECHNOLAS TENEO 317 Excimer Laser Product Overview

TECHNOLAS TENEO 317 Excimer Laser Clinical Trial

Ultra Plus Powers Lens

Ultra Plus Powers Lens Product Overview

XUV-003: Aphakia

XUV-003: Aphakia Product Overview

XUV-004: SVS

XUV-004: SVS Product Overview

XUV-007: MF

XUV-007: MF Product Overview

XUV-009: SVS

XUV-009: SVS Product Overview

XUV-010: Astigmatism

XUV-010: Astigmatism Product Overview

XUV-011: MF

XUV-011: MF Product Overview

XUV-012: SVS

XUV-012: SVS Product Overview

XUV-013: Astigmatism

XUV-013: Astigmatism Product Overview

XUV-014: Presbyopia

XUV-014: Presbyopia Product Overview

XUV-015: MF

XUV-015: MF Product Overview

Bausch & Lomb Inc-Key Competitors

Bausch & Lomb Inc-Key Employees

Bausch & Lomb Inc-Key Employee Biographies

Bausch & Lomb Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Bausch & Lomb Inc, Recent Developments

Apr 29, 2019: Bausch + lomb announces update from antibiotic Antibiotic Resistance Monitoring in Ocular MicRoorganisms (armor) study

Apr 29, 2019: Bausch + lomb invites surgeons to new in-booth experience exchange, events and scientific presentations during the annual meeting of the Annual Meeting of the American Society of Cataract and Refractive Surgery

Apr 29, 2019: Bausch + Lomb announces new scientific analyses featuring surgical and pharmaceutical products will be presented during The Annual Meeting Of The American Society Of Cataract And Refractive Surgery

Apr 26, 2019: Bausch + Lomb presents on Stellaris Elite Vision Enhancement System during The Association For Research In Vision And Ophthalmology Meeting

Apr 22, 2019: Bausch + Lomb reports more than 9.2 million units of contact lens materials diverted from waste stream through ONE by ONE recycling program

Apr 22, 2019: Bausch + Lomb to initiate series of U.S. Clinical trials for Technolas Teneo Excimer Laser

Feb 13, 2019: Bausch + Lomb receives 510(k) clearance for use of the Tangible Hydra-PEG Custom Contact Lens Coating Technology on Several of Its Boston Gas Permeable Lens Materials and Zenlens family of Scleral Lenses

Jan 22, 2019: Bausch + Lomb introduces Zen Multifocal scleral lens for Presbyopia

Dec 05, 2018: Bausch + Lomb receives 510(K) clearance from FDA For Bausch + Lomb Ultra Multifocal for Astigmatism Contact Lenses

Nov 15, 2018: Bausch + Lomb reports more than five million units of contact lens materials recycled by second anniversary of one by one recycling program

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Bausch & Lomb Inc Pipeline Products by Equipment Type

Bausch & Lomb Inc Pipeline Products by Development Stage

Bausch & Lomb Inc Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Bausch & Lomb Inc Pipeline Products and Ongoing Clinical Trials Overview

Bausch & Lomb Inc Pipeline Products by Equipment Type

Bausch & Lomb Inc Pipeline Products by Indication

Bausch & Lomb Inc Ongoing Clinical Trials by Trial Status

Bausch & Lomb Inc, Key Facts

Bausch & Lomb Inc, Major Products and Services

Bausch & Lomb Inc Number of Pipeline Products by Development Stage

Bausch & Lomb Inc Pipeline Products Summary by Development Stage

Bausch & Lomb Inc Ongoing Clinical Trials by Trial Status

Bausch & Lomb Inc Ongoing Clinical Trials Summary

Aqualox SiHy Daily Lens-Product Status

Aqualox SiHy Daily Lens-Product Description

Bausch + Lomb ULTRA Presbyopia Contact Lens-Product Status

Bausch + Lomb ULTRA Presbyopia Contact Lens-Product Description

BLC-001: SVS-Product Status

BLC-001: SVS-Product Description

BLC-002: SVS-Product Status

BLC-002: SVS-Product Description

BLC-003: SVS/MF/fA-Product Status

BLC-003: SVS/MF/fA-Product Description

BLC-004: Toric-Product Status

BLC-004: Toric-Product Description

BLC-005: SVS/MF-Product Status

BLC-005: SVS/MF-Product Description

BLC-006: SVS-Product Status

BLC-006: SVS-Product Description

BLC-007: MF-Product Status

BLC-007: MF-Product Description

BLC-008: Astigmatism-Product Status

BLC-008: Astigmatism-Product Description

BLC-009: Astigmatism-Product Status

BLC-009: Astigmatism-Product Description

BLS-001: Cataract-Product Status

BLS-001: Cataract-Product Description

BLS-002: Cataract-Product Status

BLS-002: Cataract-Product Description

BLS-003: Cataract-Product Status

BLS-003: Cataract-Product Description

BLS-004: Cataract-Product Status

BLS-004: Cataract-Product Description

BLS-005: Retina-Product Status

BLS-005: Retina-Product Description

BLS-006: Cataract-Product Status

BLS-006: Cataract-Product Description

BLS-007: Cataract-Product Status

BLS-007: Cataract-Product Description

BLS-008: Cataract-Product Status

BLS-008: Cataract-Product Description

BLS-009: Retina-Product Status

BLS-009: Retina-Product Description

BLS-010: Cataract-Product Status

BLS-010: Cataract-Product Description

BLS-011: Cataract-Product Status

BLS-011: Cataract-Product Description

BLS-012: Retina-Product Status

BLS-012: Retina-Product Description

BLS-013: Retina-Product Status

BLS-013: Retina-Product Description

BLS-014: Refractive-Product Status

BLS-014: Refractive-Product Description

BLS-015: Cataract-Product Status

BLS-015: Cataract-Product Description

BLS-016: Cataract-Product Status

BLS-016: Cataract-Product Description

BLS-018: Retina-Product Status

BLS-018: Retina-Product Description

BLS-019: Retina-Product Status

BLS-019: Retina-Product Description

BLS-020: Retina-Product Status

BLS-020: Retina-Product Description

BLS-021: Retina-Product Status

BLS-021: Retina-Product Description

BLS-022: Retina-Product Status

BLS-022: Retina-Product Description

BLS-023: Retina-Product Status

BLS-023: Retina-Product Description

BLS-024: Retina-Product Status

BLS-024: Retina-Product Description

BLS-025: Retina-Product Status

BLS-025: Retina-Product Description

BLS-026: Retina-Product Status

BLS-026: Retina-Product Description

BLS-027: Retina-Product Status

BLS-027: Retina-Product Description

BLS-028: Retina-Product Status

BLS-028: Retina-Product Description

BLS-029: Retina-Product Status

BLS-029: Retina-Product Description

BLS-030: Retina-Product Status

BLS-030: Retina-Product Description

BLS-031: Retina-Product Status

BLS-031: Retina-Product Description

Custom Soft Contact Lens-Product Status

Custom Soft Contact Lens-Product Description

Customlens-Product Status

Customlens-Product Description

enVista MX60EF Trifocal IOL-Product Status

enVista MX60EF Trifocal IOL-Product Description

enVista MX60EF Trifocal IOL-A Prospective, Multicenter, Randomized, Active-controlled Clinical Study to Evaluate the Safety and Effectiveness of the enVista One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract Extraction

LAV-001: Aphakia-Product Status

LAV-001: Aphakia-Product Description

Ophthalmic Viscosurgical Device-Product Status

Ophthalmic Viscosurgical Device-Product Description

Sarfarazi Elliptical Accommodating IOL-Product Status

Sarfarazi Elliptical Accommodating IOL-Product Description

TECHNOLAS TENEO 317 Excimer Laser-Product Status

TECHNOLAS TENEO 317 Excimer Laser-Product Description

TECHNOLAS TENEO 317 Excimer Laser-A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser Using LASIK

Ultra Plus Powers Lens-Product Status

Ultra Plus Powers Lens-Product Description

XUV-003: Aphakia-Product Status

XUV-003: Aphakia-Product Description

XUV-004: SVS-Product Status

XUV-004: SVS-Product Description

XUV-007: MF-Product Status

XUV-007: MF-Product Description

XUV-009: SVS-Product Status

XUV-009: SVS-Product Description

XUV-010: Astigmatism-Product Status

XUV-010: Astigmatism-Product Description

XUV-011: MF-Product Status

XUV-011: MF-Product Description

XUV-012: SVS-Product Status

XUV-012: SVS-Product Description

XUV-013: Astigmatism-Product Status

XUV-013: Astigmatism-Product Description

XUV-014: Presbyopia-Product Status

XUV-014: Presbyopia-Product Description

XUV-015: MF-Product Status

XUV-015: MF-Product Description

Bausch & Lomb Inc, Key Employees

Bausch & Lomb Inc, Key Employee Biographies

Bausch & Lomb Inc, Other Locations

Bausch & Lomb Inc, Subsidiaries

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Bausch & Lomb Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Abbott Medical Optics Inc

Carl Zeiss Meditec AG

Essilor International Compagnie Generale d'Optique SA

Johnson & Johnson Vision Care Inc

Harrow Health Inc

CooperVision Inc